{"pmid":32438806,"title":"A novel one-step single-tube nested quantitative Real-Time PCR assay for highly sensitive detection of SARS-CoV-2.","text":["A novel one-step single-tube nested quantitative Real-Time PCR assay for highly sensitive detection of SARS-CoV-2.","Coronavirus disease 2019 (COVID-19) has become a public health emergency. The reverse transcriptase real-time quantitative PCR (qRT-PCR) test is currently considered as a gold standard in the laboratory for the etiological detection of COVID-19. However, qRT-PCR results could be false-negative due to the inadequate sensitivity of qRT-PCR. In this study, we have developed and evaluated a novel one-step single-tube nested quantitative Real-Time PCR (OSN-qRT-PCR) assay for highly sensitive detection of SARS-CoV-2 targeting the ORF1aband N genes. The sensitivity of the OSN-qRT-PCR assay was 1 copy/reaction and 10-fold higher than that of commercial qRT-PCR kit (10 copies/reaction). The clinical performance of the OSN-qRT-PCR assay was evaluated using 181 clinical samples. Among them, 14 qRT-PCR-negative samples (7 had no repetitive results, and 7 had no Ct values) were detected by OSN-qRT-PCR. Moreover, the 7qRT-PCR-positives in the qRT-PCR grey zone (Ct value of ORF1ab ranged from 37.48 to 39.07, and Ct value of N ranged from 37.34 to 38.75) were out of the grey zone thus were deemed to be positive by OSN-qRT-PCR, indicating the positivity of these samples is confirmative. Compared to the qRT-PCR kit, OSN-qRT-PCR assay revealed higher sensitivity and specificity hence better suited to clinical applications for the detection of SARS-CoV-2 in patients with low viral load.","Anal Chem","Wang, Ji","Cai, Kun","Zhang, Ruiqing","He, Xiaozhou","Shen, Xinxin","Liu, Jun","Xu, Junqiang","Qiu, Feng","Lei, Wenwen","Wang, Jinrong","Li, Xinna","Gao, Yuan","Jiang, Yongzhong","Xu, Wenbo","Ma, Xuejun","32438806"],"abstract":["Coronavirus disease 2019 (COVID-19) has become a public health emergency. The reverse transcriptase real-time quantitative PCR (qRT-PCR) test is currently considered as a gold standard in the laboratory for the etiological detection of COVID-19. However, qRT-PCR results could be false-negative due to the inadequate sensitivity of qRT-PCR. In this study, we have developed and evaluated a novel one-step single-tube nested quantitative Real-Time PCR (OSN-qRT-PCR) assay for highly sensitive detection of SARS-CoV-2 targeting the ORF1aband N genes. The sensitivity of the OSN-qRT-PCR assay was 1 copy/reaction and 10-fold higher than that of commercial qRT-PCR kit (10 copies/reaction). The clinical performance of the OSN-qRT-PCR assay was evaluated using 181 clinical samples. Among them, 14 qRT-PCR-negative samples (7 had no repetitive results, and 7 had no Ct values) were detected by OSN-qRT-PCR. Moreover, the 7qRT-PCR-positives in the qRT-PCR grey zone (Ct value of ORF1ab ranged from 37.48 to 39.07, and Ct value of N ranged from 37.34 to 38.75) were out of the grey zone thus were deemed to be positive by OSN-qRT-PCR, indicating the positivity of these samples is confirmative. Compared to the qRT-PCR kit, OSN-qRT-PCR assay revealed higher sensitivity and specificity hence better suited to clinical applications for the detection of SARS-CoV-2 in patients with low viral load."],"journal":"Anal Chem","authors":["Wang, Ji","Cai, Kun","Zhang, Ruiqing","He, Xiaozhou","Shen, Xinxin","Liu, Jun","Xu, Junqiang","Qiu, Feng","Lei, Wenwen","Wang, Jinrong","Li, Xinna","Gao, Yuan","Jiang, Yongzhong","Xu, Wenbo","Ma, Xuejun"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32438806","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1021/acs.analchem.0c01884","topics":["Diagnosis"],"weight":1,"_version_":1667523504798433280,"score":9.490897,"similar":[{"pmid":32422410,"title":"A multiple center clinical evaluation of an ultra-fast single-tube assay for SARS-CoV-2 RNA.","text":["A multiple center clinical evaluation of an ultra-fast single-tube assay for SARS-CoV-2 RNA.","OBJECTIVES: To evaluate the performance of an ultra-fast single-tube nucleic acid isothermal amplification detection assay for SARS-CoV-2 RNA using clinical samples from multiple centers. METHODS: A reverse transcription recombinase-aided amplification (RT-RAA) assay for SARS-CoV-2 was conducted within 15minutesat39 degrees C with portable instruments after addition of extracted RNA. The clinical performance of RT-RAA assay was evaluated using 947 clinical samples from five institutions in four regions of China, and the approved commercial real-time fluorescent RT-PCR (qRT-PCR) kits were used for parallel detection. The sensitivity and specificity of RT-RAA were compared and analyzed. RESULTS: The RT-RAA test results of 926 samples were consistent with those of qRT-PCR (330 were positive, 596 were negative) and 21 were inconsistent. The sensitivity and specificity of RT-RAA was 97.63% [330/338, 95% confidence interval (CI): 95.21 to 98.90] and 97.87% (596/609, 95% CI: 96.28 to 98.81), respectively. The positive predictive value (PPV) and negative predictive value (NPV) were 96.21% (330/343, 95% CI: 93.45 to 97.88), and 98.68% (596/604, 95% CI: 97.30 to 99.38), respectively. The total coincidence rate was 97.78% (926/947, 95% CI: 96.80 to 98.70) and the Kappa was 0.952 (P <0.05). CONCLUSION: With comparable sensitivity and specificity to the commercial qRT-PCR kits, RT-RAA assay for SARS-CoV-2 exhibited distinctive advantages of simplicity and rapidity in terms of operation and turn-around time.","Clin Microbiol Infect","Wang, Ji","Cai, Kun","He, Xiaozhou","Shen, Xinxin","Wang, Jinrong","Liu, Jun","Xu, Junqiang","Qiu, Feng","Lei, Wenwen","Cui, Lunbiao","Ge, Yiyue","Wu, Tao","Zhang, Yanjun","Yan, Hao","Chen, Yin","Yu, Jiezhong","Ma, Xiaojun","Shi, Hua","Zhang, Ruiqing","Li, Xinna","Gao, Yuan","Niu, Peihua","Tan, Wenjie","Wu, Guizhen","Jiang, Yongzhong","Xu, Wenbo","Ma, Xuejun","32422410"],"abstract":["OBJECTIVES: To evaluate the performance of an ultra-fast single-tube nucleic acid isothermal amplification detection assay for SARS-CoV-2 RNA using clinical samples from multiple centers. METHODS: A reverse transcription recombinase-aided amplification (RT-RAA) assay for SARS-CoV-2 was conducted within 15minutesat39 degrees C with portable instruments after addition of extracted RNA. The clinical performance of RT-RAA assay was evaluated using 947 clinical samples from five institutions in four regions of China, and the approved commercial real-time fluorescent RT-PCR (qRT-PCR) kits were used for parallel detection. The sensitivity and specificity of RT-RAA were compared and analyzed. RESULTS: The RT-RAA test results of 926 samples were consistent with those of qRT-PCR (330 were positive, 596 were negative) and 21 were inconsistent. The sensitivity and specificity of RT-RAA was 97.63% [330/338, 95% confidence interval (CI): 95.21 to 98.90] and 97.87% (596/609, 95% CI: 96.28 to 98.81), respectively. The positive predictive value (PPV) and negative predictive value (NPV) were 96.21% (330/343, 95% CI: 93.45 to 97.88), and 98.68% (596/604, 95% CI: 97.30 to 99.38), respectively. The total coincidence rate was 97.78% (926/947, 95% CI: 96.80 to 98.70) and the Kappa was 0.952 (P <0.05). CONCLUSION: With comparable sensitivity and specificity to the commercial qRT-PCR kits, RT-RAA assay for SARS-CoV-2 exhibited distinctive advantages of simplicity and rapidity in terms of operation and turn-around time."],"journal":"Clin Microbiol Infect","authors":["Wang, Ji","Cai, Kun","He, Xiaozhou","Shen, Xinxin","Wang, Jinrong","Liu, Jun","Xu, Junqiang","Qiu, Feng","Lei, Wenwen","Cui, Lunbiao","Ge, Yiyue","Wu, Tao","Zhang, Yanjun","Yan, Hao","Chen, Yin","Yu, Jiezhong","Ma, Xiaojun","Shi, Hua","Zhang, Ruiqing","Li, Xinna","Gao, Yuan","Niu, Peihua","Tan, Wenjie","Wu, Guizhen","Jiang, Yongzhong","Xu, Wenbo","Ma, Xuejun"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32422410","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.cmi.2020.05.007","keywords":["covid-19","rt-raa","sars-cov-2","detection","multicenter evaluation"],"locations":["China","Kappa"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1667159284602896385,"score":671.8687},{"pmid":32448084,"title":"Analytical comparisons of SARS-COV-2 detection by qRT-PCR and ddPCR with multiple primer/probe sets.","text":["Analytical comparisons of SARS-COV-2 detection by qRT-PCR and ddPCR with multiple primer/probe sets.","Different primers/probes sets have been developed all over the world for the nucleic acid detection of SARS-CoV-2 by quantitative real time polymerase chain reaction (qRT-PCR) as a standard method. In our recent study, we explored the feasibility of droplet digital PCR (ddPCR) for clinical SARS-CoV-2 nucleic acid detection compared with qRT-PCR using the same primer/probe sets issued by Chinese Center for Disease Control and Prevention (CDC) targeting viral ORF1ab or N gene, which showed that ddPCR could largely minimize the false negatives reports resulted by qRT-PCR [1]. Here, we further stringently compared the performance of qRT-PCR and ddPCR for 8 primer/probe sets with the same clinical samples and conditions. Results showed that none of 8 primer/probe sets used in qRT-PCR could significantly distinguish true negatives and positives with low viral load (10(-4) dilution). Moreover, false positive reports of qRT-PCR with UCDC-N1, N2 and CCDC-N primers/probes sets were observed. In contrast, ddPCR showed significantly better performance in general for low viral load samples compared to qRT-PCR. Remarkably, the background readouts of ddPCR are relatively lower, which could efficiently reduce the production of false positive reports.","Emerg Microbes Infect","Liu, Xinjin","Feng, Jiangpeng","Zhang, Qiuhan","Guo, Dong","Zhang, Lu","Suo, Tao","Hu, Wenjia","Guo, Ming","Wang, Xin","Huang, Zhixiang","Xiong, Yong","Chen, Guozhong","Chen, Yu","Lan, Ke","32448084"],"abstract":["Different primers/probes sets have been developed all over the world for the nucleic acid detection of SARS-CoV-2 by quantitative real time polymerase chain reaction (qRT-PCR) as a standard method. In our recent study, we explored the feasibility of droplet digital PCR (ddPCR) for clinical SARS-CoV-2 nucleic acid detection compared with qRT-PCR using the same primer/probe sets issued by Chinese Center for Disease Control and Prevention (CDC) targeting viral ORF1ab or N gene, which showed that ddPCR could largely minimize the false negatives reports resulted by qRT-PCR [1]. Here, we further stringently compared the performance of qRT-PCR and ddPCR for 8 primer/probe sets with the same clinical samples and conditions. Results showed that none of 8 primer/probe sets used in qRT-PCR could significantly distinguish true negatives and positives with low viral load (10(-4) dilution). Moreover, false positive reports of qRT-PCR with UCDC-N1, N2 and CCDC-N primers/probes sets were observed. In contrast, ddPCR showed significantly better performance in general for low viral load samples compared to qRT-PCR. Remarkably, the background readouts of ddPCR are relatively lower, which could efficiently reduce the production of false positive reports."],"journal":"Emerg Microbes Infect","authors":["Liu, Xinjin","Feng, Jiangpeng","Zhang, Qiuhan","Guo, Dong","Zhang, Lu","Suo, Tao","Hu, Wenjia","Guo, Ming","Wang, Xin","Huang, Zhixiang","Xiong, Yong","Chen, Guozhong","Chen, Yu","Lan, Ke"],"date":"2020-05-26T11:00:00Z","year":2020,"_id":"32448084","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1080/22221751.2020.1772679","keywords":["sars-cov-2","diagnosis","digital pcr","false negative","false positive","real time pcr"],"topics":["Diagnosis"],"weight":1,"_version_":1667785214063017984,"score":659.46875},{"pmid":32504944,"title":"Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: Experiences of a general hospital.","text":["Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: Experiences of a general hospital.","BACKGROUND: The COVID-19 Ag (Antigen) Respi-Strip assay is a new immunochromatographic diagnostic tool recently available for antigenic diagnosis of SARS-CoV-2. The proposed sensitivity is not higher than 60 %, but its high specificity allows both quick decisions for the management of patients and confirmation by molecular diagnosis for only negative tests. However, from the first tests performed, we suspected that the sensitivity observed with routine use was much lower than that announced by the manufacturer. MATERIALS AND METHODS: Over a period of one month, we compared the negative results obtained with the COVID-19 Ag Respi-Strip kit with those obtained from qRT-PCR performed in a laboratory qualified for the molecular diagnosis of SARS-CoV-2. All samples tested were naso-pharyngeal smears from UTM-RT medium. RESULTS: Of 774 patients tested, 714 negative samples were sent for confirmation, and 159 were found to be positive by qRT-PCR. The median positive percentage agreement was 23.9 % (95 % CI: 14.2 %-38.2 %). The Cohen's kappa score was 0.35. CONCLUSION: Using this immunochromatographic assay as a triage test did not significantly reduce the number of samples outsourced for COVID-19 confirmation by qRT-PCR. In addition, even if the turn-around time is short, the assay is completely manual, which is not suitable for large volumes of routine samples. The sensitivity of this rapid test is poor, and improvements are needed to enhance its performance.","J Clin Virol","Blairon, Laurent","Wilmet, Alain","Beukinga, Ingrid","Tre-Hardy, Marie","32504944"],"abstract":["BACKGROUND: The COVID-19 Ag (Antigen) Respi-Strip assay is a new immunochromatographic diagnostic tool recently available for antigenic diagnosis of SARS-CoV-2. The proposed sensitivity is not higher than 60 %, but its high specificity allows both quick decisions for the management of patients and confirmation by molecular diagnosis for only negative tests. However, from the first tests performed, we suspected that the sensitivity observed with routine use was much lower than that announced by the manufacturer. MATERIALS AND METHODS: Over a period of one month, we compared the negative results obtained with the COVID-19 Ag Respi-Strip kit with those obtained from qRT-PCR performed in a laboratory qualified for the molecular diagnosis of SARS-CoV-2. All samples tested were naso-pharyngeal smears from UTM-RT medium. RESULTS: Of 774 patients tested, 714 negative samples were sent for confirmation, and 159 were found to be positive by qRT-PCR. The median positive percentage agreement was 23.9 % (95 % CI: 14.2 %-38.2 %). The Cohen's kappa score was 0.35. CONCLUSION: Using this immunochromatographic assay as a triage test did not significantly reduce the number of samples outsourced for COVID-19 confirmation by qRT-PCR. In addition, even if the turn-around time is short, the assay is completely manual, which is not suitable for large volumes of routine samples. The sensitivity of this rapid test is poor, and improvements are needed to enhance its performance."],"journal":"J Clin Virol","authors":["Blairon, Laurent","Wilmet, Alain","Beukinga, Ingrid","Tre-Hardy, Marie"],"date":"2020-06-07T11:00:00Z","year":2020,"_id":"32504944","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.jcv.2020.104472","keywords":["antigen testing","covid-19","point-of-care","rapid diagnosis","sars-cov-2","qrt-pcr"],"locations":["Respi-Strip"],"topics":["Diagnosis"],"weight":1,"_version_":1668892488320942080,"score":539.7879},{"pmid":32306853,"title":"Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2.","text":["Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2.","The previous outbreaks of SARS-CoV and MERS-CoV have led researchers to study the role of diagnostics in impediment of further spread and transmission. With the recent emergence of the novel SARS-CoV-2, the availability of rapid, sensitive, and reliable diagnostic methods is essential for disease control. Hence, we have developed a reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for the specific detection of SARS-CoV-2. The primer sets for RT-LAMP assay were designed to target the nucleocapsid gene of the viral RNA, and displayed a detection limit of 10(2) RNA copies close to that of qRT-PCR. Notably, the assay has exhibited a rapid detection span of 30 min combined with the colorimetric visualization. This test can detect specifically viral RNAs of the SARS-CoV-2 with no cross-reactivity to related coronaviruses, such as HCoV-229E, HCoV-NL63, HCoV-OC43, and MERS-CoV as well as human infectious influenza viruses (type B, H1N1pdm, H3N2, H5N1, H5N6, H5N8, and H7N9), and other respiratory disease-causing viruses (RSVA, RSVB, ADV, PIV, MPV, and HRV). Furthermore, the developed RT-LAMP assay has been evaluated using specimens collected from COVID-19 patients that exhibited high agreement to the qRT-PCR. Our RT-LAMP assay is simple to perform, less expensive, time-efficient, and can be used in clinical laboratories for preliminary detection of SARS-CoV-2 in suspected patients. In addition to the high sensitivity and specificity, this isothermal amplification conjugated with a single-tube colorimetric detection method may contribute to the public health responses and disease control, especially in the areas with limited laboratory capacities.","Emerg Microbes Infect","Baek, Yun Hee","Um, Jihye","Antigua, Khristine Joy C","Park, Ji-Hyun","Kim, Yeonjae","Oh, Sol","Kim, Young-Il","Choi, Won-Suk","Kim, Seong Gyu","Jeong, Ju Hwan","Chin, Bum Sik","Nicolas, Halcyon Dawn G","Ahn, Ji-Young","Shin, Kyeong Seob","Choi, Young Ki","Park, Jun-Sun","Song, Min-Suk","32306853"],"abstract":["The previous outbreaks of SARS-CoV and MERS-CoV have led researchers to study the role of diagnostics in impediment of further spread and transmission. With the recent emergence of the novel SARS-CoV-2, the availability of rapid, sensitive, and reliable diagnostic methods is essential for disease control. Hence, we have developed a reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for the specific detection of SARS-CoV-2. The primer sets for RT-LAMP assay were designed to target the nucleocapsid gene of the viral RNA, and displayed a detection limit of 10(2) RNA copies close to that of qRT-PCR. Notably, the assay has exhibited a rapid detection span of 30 min combined with the colorimetric visualization. This test can detect specifically viral RNAs of the SARS-CoV-2 with no cross-reactivity to related coronaviruses, such as HCoV-229E, HCoV-NL63, HCoV-OC43, and MERS-CoV as well as human infectious influenza viruses (type B, H1N1pdm, H3N2, H5N1, H5N6, H5N8, and H7N9), and other respiratory disease-causing viruses (RSVA, RSVB, ADV, PIV, MPV, and HRV). Furthermore, the developed RT-LAMP assay has been evaluated using specimens collected from COVID-19 patients that exhibited high agreement to the qRT-PCR. Our RT-LAMP assay is simple to perform, less expensive, time-efficient, and can be used in clinical laboratories for preliminary detection of SARS-CoV-2 in suspected patients. In addition to the high sensitivity and specificity, this isothermal amplification conjugated with a single-tube colorimetric detection method may contribute to the public health responses and disease control, especially in the areas with limited laboratory capacities."],"journal":"Emerg Microbes Infect","authors":["Baek, Yun Hee","Um, Jihye","Antigua, Khristine Joy C","Park, Ji-Hyun","Kim, Yeonjae","Oh, Sol","Kim, Young-Il","Choi, Won-Suk","Kim, Seong Gyu","Jeong, Ju Hwan","Chin, Bum Sik","Nicolas, Halcyon Dawn G","Ahn, Ji-Young","Shin, Kyeong Seob","Choi, Young Ki","Park, Jun-Sun","Song, Min-Suk"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32306853","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1080/22221751.2020.1756698","keywords":["covid-19","sars-cov-2","colorimetric detection","molecular diagnosis","novel coronavirus","reverse transcription-loop-mediated isothermal amplification"],"topics":["Diagnosis"],"weight":1,"_version_":1666138491234287617,"score":530.6543},{"pmid":32379863,"title":"Metagenomic analysis reveals clinical SARS-CoV-2 infection and bacterial or viral superinfection and colonization.","text":["Metagenomic analysis reveals clinical SARS-CoV-2 infection and bacterial or viral superinfection and colonization.","BACKGROUND: More than two months separated the initial description of SARS-CoV-2 and discovery of its widespread dissemination in the United States. Despite this lengthy interval, implementation of specific quantitative reverse transcription (qRT)-PCR-based SARS-CoV-2 tests in the US has been slow, and testing is still not widely available. Metagenomic sequencing offers the promise of unbiased detection of emerging pathogens, without requiring prior knowledge of the identity of the responsible agent or its genomic sequence. METHODS: To evaluate metagenomic approaches in the context of the current SARS-CoV-2 epidemic, laboratory-confirmed positive and negative samples from Seattle, Washington were evaluated by metagenomic sequencing, with comparison to a 2019 reference genomic database created before the emergence of SARS-CoV-2. RESULTS: Within 36 hours our results showed clear identification of a novel human Betacoronavirus, closely related to known Betacoronaviruses of bats, in laboratory-proven cases of SARS-CoV-2. A subset of samples also showed superinfection or colonization with human parainfluenza virus 3 or Moraxella species, highlighting the need to test directly for SARS-CoV-2 as opposed to ruling out an infection using a viral respiratory panel. Samples negative for SARS-CoV-2 by RT-PCR were also negative by metagenomic analysis, and positive for Rhinovirus A and C. Unlike targeted SARS-CoV-2 qRT-PCR testing, metagenomic analysis of these SARS-CoV-2 negative samples identified candidate etiological agents for the patients' respiratory symptoms. CONCLUSION: Taken together, these results demonstrate the value of metagenomic analysis in the monitoring and response to this and future viral pandemics.","Clin Chem","Peddu, Vikas","Shean, Ryan C","Xie, Hong","Shrestha, Lasata","Perchetti, Garrett A","Minot, Samuel S","Roychoudhury, Pavitra","Huang, Meei-Li","Nalla, Arun","Reddy, Shriya B","Phung, Quynh","Reinhardt, Adam","Jerome, Keith R","Greninger, Alexander L","32379863"],"abstract":["BACKGROUND: More than two months separated the initial description of SARS-CoV-2 and discovery of its widespread dissemination in the United States. Despite this lengthy interval, implementation of specific quantitative reverse transcription (qRT)-PCR-based SARS-CoV-2 tests in the US has been slow, and testing is still not widely available. Metagenomic sequencing offers the promise of unbiased detection of emerging pathogens, without requiring prior knowledge of the identity of the responsible agent or its genomic sequence. METHODS: To evaluate metagenomic approaches in the context of the current SARS-CoV-2 epidemic, laboratory-confirmed positive and negative samples from Seattle, Washington were evaluated by metagenomic sequencing, with comparison to a 2019 reference genomic database created before the emergence of SARS-CoV-2. RESULTS: Within 36 hours our results showed clear identification of a novel human Betacoronavirus, closely related to known Betacoronaviruses of bats, in laboratory-proven cases of SARS-CoV-2. A subset of samples also showed superinfection or colonization with human parainfluenza virus 3 or Moraxella species, highlighting the need to test directly for SARS-CoV-2 as opposed to ruling out an infection using a viral respiratory panel. Samples negative for SARS-CoV-2 by RT-PCR were also negative by metagenomic analysis, and positive for Rhinovirus A and C. Unlike targeted SARS-CoV-2 qRT-PCR testing, metagenomic analysis of these SARS-CoV-2 negative samples identified candidate etiological agents for the patients' respiratory symptoms. CONCLUSION: Taken together, these results demonstrate the value of metagenomic analysis in the monitoring and response to this and future viral pandemics."],"journal":"Clin Chem","authors":["Peddu, Vikas","Shean, Ryan C","Xie, Hong","Shrestha, Lasata","Perchetti, Garrett A","Minot, Samuel S","Roychoudhury, Pavitra","Huang, Meei-Li","Nalla, Arun","Reddy, Shriya B","Phung, Quynh","Reinhardt, Adam","Jerome, Keith R","Greninger, Alexander L"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32379863","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1093/clinchem/hvaa106","locations":["United States","US","Seattle","Washington"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Mechanism","Diagnosis"],"weight":1,"_version_":1666262687616598016,"score":465.82758}]}